Today we recognised the generosity of the Australian Cancer Research Foundation (ACRF) for their $2m research grant which has provided researchers from Peter Mac and our VCCC partners with cutting edge tech which will help them break new ground in cancer research.
The grant provided funding for five critical pieces of equipment housed within Peter Mac’s laboratories.
At today’s event, Peter Mac researchers explained how these research technologies are supporting their studies of tumour heterogeneity and enabling them to translate their laboratory-based discoveries into their clinical or research specialisations.
Professor Rodney Hicks and Associate Professor Sarah-Jane Dawson shared examples of how the items of equipment have catalysed the translational elements of their research.
And Executive Director of Cancer Research Ricky Johnstone and Professor Mark Dawson provided an update on some exciting projects in the areas of Cancer Immunology and Cancer Epigenetics and how fundamental scientific discoveries form the foundation for future clinical development of anti-cancer agents.
The pieces of equipment funded by the ACRF grant include:
- Genomics: Molecular Genomics Core (MGC): The Illumina NextSeq500sequencer, which was installed in April 2017.
- Functional Cancer Genomics: Victorian Centre for Functional Genomics and Reverse Phase Protein Array platform (VCFG/RPPA): The VCFG had the Janus G3 robot installed in December 2017.
- Cellular Imaging: Centre for Advanced Histology and Microscopy (CAHM). Our high resolution in vitro cell microscopy has been greatly enhanced through the acquisition of the Olympus FV3000 confocal microscope, which was also received in 2017.
- Flow Cytometry: Flow Cytometry Facility (FCF) The BD FACSymphony Flow Cytometer was installed in January 2018.
- Pre-clinical imaging: Preclinical Imaging Facility (PCI) The G8 PET/CT Preclinical Imaging System was installed in February 2018.